{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:54:01Z","timestamp":1761562441575,"version":"3.40.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijcard.2018.11.030","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T12:03:42Z","timestamp":1542283422000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8171-7617","authenticated-orcid":false,"given":"Tobias","family":"Schupp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Behnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Bollow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Taton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Ellguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko","family":"Engelke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzair","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Wei\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Nienaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muharrem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambis","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ijcard.2018.11.030_bb0005","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJMra000650","article-title":"Sudden death due to cardiac arrhythmias","volume":"345","author":"Huikuri","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2018.11.030_bb0010","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s12350-016-0600-6","article-title":"Mechanisms of sudden cardiac death","volume":"23","author":"McElwee","year":"2016","journal-title":"J. Nucl. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2018.11.030_bb0015","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI26381","article-title":"Mechanisms of sudden cardiac death","volume":"115","author":"Rubart","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"22","key":"10.1016\/j.ijcard.2018.11.030_bb0020","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/01.CIR.0000129322.97266.F3","article-title":"Implantable defibrillators and sudden cardiac death","volume":"109","author":"Josephson","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2018.11.030_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2018.11.030_bb0030","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2018.11.030_bb0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0002-9149(97)00078-7","article-title":"Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment","volume":"79","author":"Barron","year":"1997","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2018.11.030_bb0040","first-page":"1","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","author":"Claro","year":"2015","journal-title":"Cochrane Libr."},{"issue":"41","key":"10.1016\/j.ijcard.2018.11.030_bb0045","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcard.2018.11.030_bb0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications","volume":"298","author":"Vassallo","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijcard.2018.11.030_bb0055","first-page":"2189","article-title":"Amiodarone: guidelines for use and monitoring","volume":"68","author":"Siddoway","year":"2003","journal-title":"Am. Fam. Physician"},{"issue":"6","key":"10.1016\/j.ijcard.2018.11.030_bb0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1085\/jgp.201511470","article-title":"A general mechanism for drug promiscuity: studies with amiodarone and other antiarrhythmics","volume":"146","author":"Rusinova","year":"2015","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ijcard.2018.11.030_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2017.03.066","article-title":"Drugs to prevent sudden cardiac death","volume":"237","author":"Erath","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2018.11.030_bb0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijcard.2018.11.030_bb0075","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.11.030_bb0080","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.12659\/MSM.890881","article-title":"Cutaneous adverse reactions of amiodarone","volume":"20","author":"Jaworski","year":"2014","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.ijcard.2018.11.030_bb0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/hrt.2003.025254","article-title":"Prediction and prevention of sudden cardiac death in heart failure","volume":"91","author":"Lane","year":"2005","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcard.2018.11.030_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia","volume":"333","author":"Singh","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2018.11.030_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of \u03b2-blockers, amiodarone plus \u03b2-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the optic study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.11.030_bb0100","article-title":"Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death","volume":"12","author":"Claro","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"41","key":"10.1016\/j.ijcard.2018.11.030_bb0105","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2018.11.030_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10557-018-6812-z","article-title":"Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia","volume":"32","author":"Schupp","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"27","key":"10.1016\/j.ijcard.2018.11.030_bb0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2018.11.030_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar. Behav. Res."},{"key":"10.1016\/j.ijcard.2018.11.030_bb0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/IJGM.S104313","article-title":"Get the most from your data: a propensity score model comparison on real-life data","volume":"9","author":"Ferdinand","year":"2016","journal-title":"Int. J. Gen. Med."},{"issue":"9146","key":"10.1016\/j.ijcard.2018.11.030_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","author":"Investigators","year":"1999","journal-title":"Lancet"},{"issue":"9169","key":"10.1016\/j.ijcard.2018.11.030_bb0135","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"9089","key":"10.1016\/j.ijcard.2018.11.030_bb0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","volume":"350","year":"1997","journal-title":"Lancet"},{"issue":"9053","key":"10.1016\/j.ijcard.2018.11.030_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT","volume":"349","author":"Julian","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcard.2018.11.030_bb0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2018.11.030_bb0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.joa.2016.02.006","article-title":"Anti-arrhythmic medications increase non-cardiac mortality - a meta-analysis of randomized control trials","volume":"32","author":"Pandya","year":"2016","journal-title":"J. Arrhythmia"},{"issue":"4","key":"10.1016\/j.ijcard.2018.11.030_bb0160","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"Europace"},{"issue":"26","key":"10.1016\/j.ijcard.2018.11.030_bb0165","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.11.030_bb0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijcard.2018.08.099","article-title":"Ventricular tachycardia ablation in structural heart disease: impact of ablation strategy and non-inducibility as an end-point on long term outcome","volume":"277","author":"Breitenstein","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2018.11.030_bb0175","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm."},{"issue":"1","key":"10.1016\/j.ijcard.2018.11.030_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/europace\/eux332","article-title":"Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association survey","volume":"20","author":"Tilz","year":"2018","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ijcard.2018.11.030_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005663","article-title":"Effect of baseline antiarrhythmic drug on outcomes with ablation in ischemic ventricular tachycardia: a VANISH substudy (ventricular tachycardia ablation versus escalated antiarrhythmic drug therapy in ischemic heart disease)","volume":"11","author":"Parkash","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.11.030_bb0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2018.11.030_bb0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.CIR.0000134957.51747.6E","article-title":"Long-term comparison of the implantable cardioverter defibrillator versus amiodarone. Eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)","volume":"110","author":"Bokhari","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2018.11.030_bb0200","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jacc.2003.11.038","article-title":"Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II)","volume":"43","author":"Greenberg","year":"2004","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318345728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318345728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T16:46:51Z","timestamp":1547743611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318345728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":40,"alternative-id":["S0167527318345728"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.030","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of beta-blocker compared to combined amiodarone therapy secondary to ventricular tachyarrhythmias","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}